Iradimed Corp. (NASDAQ: IRMD) reported Q3 EPS of $0.19, $0.03 better than the analyst estimate of $0.16. Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7.7 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.